{"id":"https://openalex.org/W41671648","doi":null,"title":"Outbreak of hypoglycaemia: sexual enhancement products containing oral hypoglycaemic agent.","display_name":"Outbreak of hypoglycaemia: sexual enhancement products containing oral hypoglycaemic agent.","publication_year":2009,"publication_date":"2009-06-01","ids":{"openalex":"https://openalex.org/W41671648","mag":"41671648","pmid":"https://pubmed.ncbi.nlm.nih.gov/19494375"},"language":"en","primary_location":{"id":"pmid:19494375","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19494375","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hong Kong medical journal = Xianggang yi xue za zhi","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048330352","display_name":"Wing\u2010Tat Poon","orcid":"https://orcid.org/0000-0002-9811-9565","observed_orcids":["https://orcid.org/0000-0002-9811-9565"]},"institutions":[{"id":"https://openalex.org/I1294586568","display_name":"Hospital Authority","ror":"https://ror.org/05sn8t512","country_code":"HK","type":"government","lineage":["https://openalex.org/I1294586568"]},{"id":"https://openalex.org/I4210131216","display_name":"Princess Margaret Hospital","ror":"https://ror.org/03jrxta72","country_code":"HK","type":"healthcare","lineage":["https://openalex.org/I1294586568","https://openalex.org/I4210131216"]}],"countries":["HK"],"is_corresponding":false,"raw_author_name":"W T Poon","raw_affiliation_strings":["Hospital Authority Toxicology Reference Laboratory, Princess Margaret Hospital, Laichikok, Hong Kong"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Authority Toxicology Reference Laboratory, Princess Margaret Hospital, Laichikok, Hong Kong","institution_ids":["https://openalex.org/I1294586568","https://openalex.org/I4210131216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110181431","display_name":"Y. H. Lam","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y H Lam","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101827036","display_name":"Han\u2010Chih Hencher Lee","orcid":"https://orcid.org/0000-0002-0162-5681","observed_orcids":["https://orcid.org/0000-0002-0162-5681"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hencher H C Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054952044","display_name":"CK Ching","orcid":"https://orcid.org/0000-0003-3434-551X","observed_orcids":["https://orcid.org/0000-0003-3434-551X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C K Ching","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"W T Chan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W T Chan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028099645","display_name":"S S Chan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S S Chan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018677121","display_name":"Christopher K.C. Lai","orcid":"https://orcid.org/0000-0001-8591-5944","observed_orcids":["https://orcid.org/0000-0001-8591-5944"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C K Lai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049875123","display_name":"Man Li Tse","orcid":"https://orcid.org/0000-0003-2456-409X","observed_orcids":["https://orcid.org/0000-0003-2456-409X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M L Tse","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100897094","display_name":"Albert Y W Chan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Albert Y W Chan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5005014908","display_name":"Tony W.L. Mak","orcid":"https://orcid.org/0000-0002-4106-7370","observed_orcids":["https://orcid.org/0000-0002-4106-7370"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tony W L Mak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.6947,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.83465649,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"15","issue":"3","first_page":"196","last_page":"200"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.006000000052154064,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11635","display_name":"Poisoning and overdose treatments","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-induced-hypoglycaemia","display_name":"drug-induced hypoglycaemia","score":0.9390000104904175},{"id":"https://openalex.org/keywords/sildenafil","display_name":"sildenafil","score":0.8970000147819519},{"id":"https://openalex.org/keywords/glibenclamide","display_name":"glibenclamide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/sexual-enhancement-products","display_name":"sexual enhancement products","score":0.8690000176429749},{"id":"https://openalex.org/keywords/over-the-counter-drugs","display_name":"over-the-counter drugs","score":0.5680000185966492},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.34599998593330383},{"id":"https://openalex.org/keywords/urine-toxicology","display_name":"urine toxicology","score":0.5630000233650208},{"id":"https://openalex.org/keywords/hong-kong","display_name":"Hong Kong","score":0.4909999966621399}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8979127407073975},{"id":"https://openalex.org/C2776768464","wikidata":"https://www.wikidata.org/wiki/Q191521","display_name":"Sildenafil","level":2,"score":0.6317374110221863},{"id":"https://openalex.org/C2779768347","wikidata":"https://www.wikidata.org/wiki/Q420626","display_name":"Glibenclamide","level":3,"score":0.6027607917785645},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.44976434111595154},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.42516374588012695},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4176230728626251},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.33172497153282166},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.33002549409866333},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29561877250671387},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.1998579502105713},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.19137105345726013},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.18625837564468384},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.12400907278060913},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.10466384887695312}],"mesh":[{"descriptor_ui":"D000068677","descriptor_name":"Sildenafil Citrate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004196","descriptor_name":"Disease Outbreaks","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005905","descriptor_name":"Glyburide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005905","descriptor_name":"Glyburide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006723","descriptor_name":"Hong Kong","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011687","descriptor_name":"Purines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011687","descriptor_name":"Purines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012725","descriptor_name":"Sexual Behavior","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013450","descriptor_name":"Sulfones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013450","descriptor_name":"Sulfones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:19494375","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19494375","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hong Kong medical journal = Xianggang yi xue za zhi","raw_type":"Journal Article"},{"id":"mag:41671648","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19494375","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2056030037","https://openalex.org/W2061022661","https://openalex.org/W3029006447","https://openalex.org/W4248948489","https://openalex.org/W1986403552","https://openalex.org/W2024337734","https://openalex.org/W2025126604","https://openalex.org/W100814681","https://openalex.org/W4281641533","https://openalex.org/W2156777899"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"describe":[2],"a":[3,121,173,223],"cluster":[4],"of":[5,45,60,80,86,108,113,133,150,191,202],"Hong":[6,34],"Kong":[7],"subjects":[8],"with":[9],"hypoglycaemia,":[10],"after":[11],"they":[12],"had":[13,115,142],"taken":[14],"various":[15],"non-prescription":[16],"sildenafil":[17,203],"products":[18,136,154,190,221,238],"containing":[19],"glibenclamide.":[20],"DESIGN:":[21],"Retrospective":[22],"study.":[23],"SETTING:":[24],"A":[25,84],"tertiary":[26],"referral":[27],"centre":[28],"for":[29,43,92,197],"clinical":[30,65],"toxicology":[31,71],"analysis":[32,72,78],"in":[33,75,104,146,157,172],"Kong.":[35],"PATIENTS:":[36],"All":[37],"men":[38],"referred":[39,91],"to":[40,52,228],"the":[41,105,181],"laboratory":[42],"investigation":[44],"suspected":[46,93],"drug-induced":[47,94],"hypoglycaemia":[48],"from":[49],"December":[50],"2007":[51],"September":[53],"2008.":[54],"MAIN":[55],"OUTCOME":[56],"MEASURES:":[57],"The":[58,148,199],"characteristics":[59],"these":[61,126,151],"patients,":[62,111],"including":[63],"their":[64,100,243],"presentations,":[66],"outcomes,":[67],"drug":[68,119],"history,":[69],"urine":[70,106],"results,":[73],"and":[74,97,176,204,213,225,230],"some":[76],"instances,":[77],"results":[79],"unused":[81,187],"products.":[82],"RESULTS:":[83],"total":[85],"144":[87],"male":[88],"patients":[89,141,168],"were":[90,102,165,195],"hypoglycaemia.":[95],"Sildenafil":[96],"glibenclamide,":[98],"or":[99,164],"metabolites,":[101],"detected":[103],"specimens":[107],"68":[109],"(47%)":[110],"none":[112],"whom":[114],"been":[116],"prescribed":[117],"either":[118],"by":[120],"registered":[122],"medical":[123],"practitioner.":[124],"Among":[125],"subjects,":[127],"24":[128],"(35%)":[129],"denied":[130],"any":[131],"use":[132],"sexual":[134,152,188],"enhancement":[135,153,189],"despite":[137],"repeated":[138,143],"questioning.":[139],"Eight":[140],"exposure":[144],"resulting":[145],"re-admission.":[147],"sources":[149],"included":[155],"pharmacies":[156],"Mainland":[158],"China,":[159],"friends,":[160],"local":[161],"pharmacies,":[162],"peddlers,":[163],"unknown.":[166],"Three":[167],"died,":[169],"one":[170,177],"remains":[171],"vegetative":[174],"state":[175],"suffered":[178],"cognitive":[179],"impairment;":[180],"remaining":[182],"63":[183],"recovered":[184,196],"fully.":[185],"Twenty-five":[186],"seven":[192],"different":[193],"kinds":[194],"analysis.":[198],"median":[200],"(range)":[201],"glibenclamide":[205],"per":[206],"unit":[207],"dose":[208],"was":[209],"64":[210],"(0.05-198)":[211],"mg":[212],"70":[214],"(0-158)":[215],"mg,":[216],"respectively.":[217],"CONCLUSION:":[218],"These":[219],"illegal":[220],"pose":[222],"severe":[224],"continued":[226],"threat":[227],"society":[229],"therefore":[231],"deserve":[232],"widespread":[233],"vigilance,":[234],"so":[235],"that":[236],"such":[237],"can":[239],"be":[240],"eradicated":[241],"at":[242],"source.":[244]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}